摘要:
Compounds selected from the group ofN-unsubstituted or N-alkylated or N-acylated 14-O-[(amino(C 0-4 )alkyl-hydroxy-cycloalkyl- or bicycloalkylsulfanyl)-acetyl]-mutilins which are 14-O-[(amino(C 0-4 )alkyl-hydroxy-cyclobutylsulfanyl)-acetyl]-mutilins, 14-O-[(amino(C 0-4 )alkyl-hydroxy-cyclopentylsulfanyl)-acetyl]-mutilins, 14-O-[(amino(C 0-4 )alkyl-hydroxy-cycloheptylsulfanyl)-acetyl]-mutilins, 14-O-[(amino(C 0-4 )alkyl-hydroxy-cyclooctylsulfanyl)-acetyl]-mutilins, or 14-O-[(amino(C 0-4 )alkyt-hydroxy-bicycloalkylsulfanyl)-acetyl]-mutilins, optionally in the form of a salt and/or a solvate, a pharmaceutical compositions comprising such compounds and their use as pharmaceuticals, e.g. for the treatment of microbial infections and for the treatment of acne, optionally in combination with other pharmaceutically active agents.
摘要:
The present invention relates to compounds of general formula I
wherein R is hydrogen and R 1 is hydroxy or acyloxy, or R is acyl and R 1 is hydroxy or acyloxy, X is sulphur, oxygen or NR 10 , wherein R 10 is hydrogen or (C 1-4 )alkyl; Y is sulphur or oxygen; R 2 is hydrogen or one or more substituents, e.g. including substituents such as conventional in organic, e.g. (pleuro)mutilin, chemistry; R4 is hydrogen or (C 1-4 )alkyl; R 5 is hydrogen or (C 1-4 )alkyl; R 3 and R 3 ' are hydrogen, deuterium, or halogen; R 6 , R 7 and R 8 are hydrogen, halogen or deuterium; m is a number selected from 0 to 4, n is a number selected from 0 to 10, and p is a number selected from 0 to 10; with the proviso that n plus p are at least 1. These compounds are useful as pharmaceuticals, particularly as antimicrobials.
摘要:
A compound selected from 14-O-[(Cycloalkyl-sulfanyl)acetyl]mutilins; 14-O-[Cycloalkyl-alkyl-sulfanyl)acetyl] mutilins; 14-O-[(Cycloalkoxy)acetyl] mutilins; or 14-O[(Cycloalkyl-alkoxy)acetyl] mutilins and its use as a pharmaceutical.
摘要:
The present invention relates to compounds of general formula I
wherein R is hydrogen and R 1 is hydroxy or acyloxy, or R is acyl and R 1 is hydroxy or acyloxy, X is sulphur, oxygen or NR 10 , wherein R 10 is hydrogen or (C 1-4 )alkyl; Y is sulphur or oxygen; R 2 is hydrogen or one or more substituents, e.g. including substituents such as conventional in organic, e.g. (pleuro)mutilin, chemistry; R4 is hydrogen or (C 1-4 )alkyl; R 5 is hydrogen or (C 1-4 )alkyl; R 3 and R 3 ' are hydrogen, deuterium, or halogen; R 6 , R 7 and R 8 are hydrogen, halogen or deuterium; m is a number selected from 0 to 4, n is a number selected from 0 to 10, and p is a number selected from 0 to 10; with the proviso that n plus p are at least 1. These compounds are useful as pharmaceuticals, particularly as antimicrobials.
摘要翻译:本发明涉及通式Ⅰ化合物,其中R为氢,R 1为羟基或酰氧基,或R为酰基,R 1为羟基或酰氧基,X为硫,氧或NR 10,其中R 10为氢或( C 1-4)烷基; Y是硫或氧; R 2是氢或一个或多个取代基,例如。 包括诸如常规的有机的取代基。 (胸膜)mutilin,化学; R4是氢或(C 1-4)烷基; R 5是氢或(C 1-4)烷基; R 3和R 3'是氢,氘或卤素; R 6,R 7和R 8是氢,卤素或氘; m是选自0至4的数,n是选自0至10的数,p是选自0至10的数; 条件是n加p至少为1.这些化合物可用作药物,特别是作为抗微生物剂。
摘要:
A compound of formula (I) wherein n is 0 to 4; m is 0 or 1 with the proviso that the sulphur atom and R3 are in vicinal position (if m = 0 then R3 is in position 2', and if m = 1 then R3 is on position 1'); R is ethyl or vinyl; R1 is hydrogen or (C1-6)alkyl; R2 is hydrogen or - (C3-6)cycloalkyl, or - unsubstituted (C1-6)alkyl, or - (C1-6)alkyl substituted by one or more of - hydroxy; preferably one or two, - methoxy, - halogen, - (C3-6)cycloalkyl, or R1 and R2 together with the nitrogen atom to which they are attached form a 5 to 7 membered heterocyclic ring containing at least 1 nitrogen atom or 1 nitrogen and 1 additional heteroatome e. g. selected from N or O, or R1 is hydroxy and R2 is formyl; R3 is OH, OR4, a halogen atom, or - with the proviso that R3 is bound to 2' R3 represents -O-(CH2)P-O- with p is 2 or 3; R4 is unsubstituted (C1-6)alkyl or (C3-6)cycloalkyl.
摘要:
The present invention relates to compounds selected from the group consisting of 14-0- [((Mono- or dialkylamino)-cycloalkylsulfanyl- or -cycloalkyl-oxy)-acetyl, -thioacetyl or - imino-oxy]-mutilins, 14-O-[((Cycloalkyl- or heterocyclylamino)-cycloalkylsulfanyl- or - cycloalkyl-oxy)-acetyl, -thioaceyl or -imino-oxy]-mutilins, 14-O-[((Heterocyc-N-yl- cycloalkyl)-sulfanyl- or -oxy)-acetyl, -thioacetyl or -imino-oxy]-mutilins, 14-O-[(((Mono- or dialkylamino)-cycloalkyl)-alkylsulfanyl- or -alkyl-oxy)-acetyl, -thioacetyl or -imino-oxy]- mutilins, 14-O-[(((Cycloalkyl- or heterocyclylamino)-cycloalkyl)-alkylsulfanyl- or -alkyl- oxy)-acetyl, -thioacetyl or -imino-oxy]-mutilins, and 14-O-[((Heterocyc-N-yl-cycloalkyl)- alkylsulfanyl- or -alkyl-oxy)-acetyl, -thioacetyl or -imino-oxy]-mutilins, and their use as pharmaceuticals.
wherein n is 0 to 4; m is 0 or 1 with the proviso that the sulphur atom and R 3 are in vicinal position (if m = 0 then R 3 is in position 2', and if m = 1 then R 3 is on position 1'); R is ethyl or vinyl; R 1 is hydrogen or (C 1-6 )alkyl, R 2 is hydrogen or - (C 3 - 6 )cycloalkyl, or - unsubstituted (C 1 - 6 )alkyl, or - (C 1 - 6 )alkyl substituted by one or more of - hydroxy; preferably one or two, - methoxy, - halogen, - (C 3 - 6 )cycloalkyl, or
R 1 and R 2 together with the nitrogen atom to which they are attached form a 5 to 7 membered heterocyclic ring containing at least 1 nitrogen atom or 1 nitrogen and 1 additional heteroatome e. g. selected from N or O, or R 1 is hydroxy and R 2 is formyl; R 3 is OH, OR 4 , a halogen atom, or - with the proviso that R 3 is bound to 2' R 3 represents -O-(CH 2 ) p -O- with p is 2 or 3;
R 4 is unsubstituted (C 1 - 6 )alkyl or (C 3 - 6 )cycloalkyl.